Back
Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings
Sponsored
RARE
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Sell
46
RARE
Ultragenyx Pharmaceutical
Last Price:
52.02
Seasonality Move:
11.62%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.Ultragenyx Pharmaceutical Price Quote
$52.02
-0.78 (-1.48%)
(Updated: October 30, 2024 at 2:30 PM ET)
Ultragenyx Pharmaceutical Key Stats
Sell
46
Ultragenyx Pharmaceutical (RARE)
is a Sell
Day range:
$52.38 - $53.48
52-week range:
$32.83 - $60.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.88
P/B ratio:
11.25%
Volume:
584.8K
Avg. volume:
594K
1-year change:
60.93%
Market cap:
$4.9B
Revenue:
$434.2M
EPS:
$-7.3
How Much Does Ultragenyx Pharmaceutical Make?
-
How Much Are Ultragenyx Pharmaceutical's Sales Annually?
RARE Revenues are $434.2M -
How Much Profit Does Ultragenyx Pharmaceutical's Make A Year?
RARE net income is -$606.6M
Is Ultragenyx Pharmaceutical Growing As A Company?
-
What Is Ultragenyx Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.36% -
What Is Ultragenyx Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ultragenyx Pharmaceutical Stock Price Performance
-
Did Ultragenyx Pharmaceutical Stock Go Up Last Month?
Ultragenyx Pharmaceutical share price went down by -2.99% last month -
Did RARE's Share Price Rise Over The Last Year?
RARE share price rose by 60.93% over the past 1 year
What Is Ultragenyx Pharmaceutical 52-Week High & Low?
-
What Is Ultragenyx Pharmaceutical’s 52-Week High Share Price?
Ultragenyx Pharmaceutical has traded as high as $60.37 over the past 52 weeks -
What Is Ultragenyx Pharmaceutical’s 52-Week Low Share Price?
Ultragenyx Pharmaceutical has traded as low as $32.83 over the past 52 weeks
Ultragenyx Pharmaceutical Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ultragenyx Pharmaceutical?
-
How Much Debt Does Ultragenyx Pharmaceutical Have?
Total long term debt quarterly is $0 -
How Much Cash Does Ultragenyx Pharmaceutical Have?
Cash and short term investments quarterly total is $763.8M -
What Is Ultragenyx Pharmaceutical’s Book Value Per Share?
Book value per share is 4.69
Is Ultragenyx Pharmaceutical Cash Flow Positive?
-
What Is RARE Cash Flow From Operations?
Cash flow from operations (TTM) is -$469.5M -
What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $740.7M -
What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
Cash flow from investing (TTM) is $112.3M
Ultragenyx Pharmaceutical Return On Invested Capital
-
Is Management Doing A Good Job?
RARE return on invested capital is -290% -
What Is Ultragenyx Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is -42% -
What Is RARE Return On Equity?
ROE is a measure of profitability and is -290%
Ultragenyx Pharmaceutical Earnings Date & Stock Price
-
What Is Ultragenyx Pharmaceutical's Stock Price Today?
A single share of RARE can be purchased today for 52.80 -
What Is Ultragenyx Pharmaceutical’s Stock Symbol?
Ultragenyx Pharmaceutical trades on the nasdaq under the ticker symbol: RARE -
When Is Ultragenyx Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Ultragenyx Pharmaceutical is scheduled on November 1, 2024 -
When Is RARE's next ex-dividend date?
Ultragenyx Pharmaceutical's next ex-dividend date is May 27, 2020 -
How To Buy Ultragenyx Pharmaceutical Stock?
You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ultragenyx Pharmaceutical Competitors
-
Who Are Ultragenyx Pharmaceutical's Competitors?
Below is a list of companies who compete with Ultragenyx Pharmaceutical or are related in some way:
Ultragenyx Pharmaceutical Dividend Yield
-
What Is RARE Dividend Yield?
Ultragenyx Pharmaceutical’s dividend yield currently is 0% -
What Is Ultragenyx Pharmaceutical’s Payout Ratio?
Ultragenyx Pharmaceutical’s payout ratio is 0% -
When Did Ultragenyx Pharmaceutical Last Pay A Dividend?
The latest dividend pay date is October 30, 2024 -
What Is Ultragenyx Pharmaceutical’s Dividend Per Share?
Ultragenyx Pharmaceutical pays a dividend of $0.00 per share
Ultragenyx Pharmaceutical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 6.9% |
Revenue: | 35.75% | 19.33% |
Analyst Recommendations
Buy Recommendations: | 13 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 91.57 |
Upside from Last Price: | 73.43% |